CN1987463A - 用于检测母系遗传线粒体耳聋基因C1494T突变的TaqMan MGB探针及其用途 - Google Patents
用于检测母系遗传线粒体耳聋基因C1494T突变的TaqMan MGB探针及其用途 Download PDFInfo
- Publication number
- CN1987463A CN1987463A CNA2006101696398A CN200610169639A CN1987463A CN 1987463 A CN1987463 A CN 1987463A CN A2006101696398 A CNA2006101696398 A CN A2006101696398A CN 200610169639 A CN200610169639 A CN 200610169639A CN 1987463 A CN1987463 A CN 1987463A
- Authority
- CN
- China
- Prior art keywords
- mgb probe
- probe
- mgb
- saltant
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000523 sample Substances 0.000 title claims abstract description 132
- 206010011878 Deafness Diseases 0.000 title claims abstract description 56
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 36
- 230000035772 mutation Effects 0.000 title claims abstract description 17
- 208000016354 hearing loss disease Diseases 0.000 title claims description 44
- 231100000895 deafness Toxicity 0.000 title claims description 41
- 230000008774 maternal effect Effects 0.000 claims abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 9
- 230000008859 change Effects 0.000 claims description 28
- 239000002773 nucleotide Substances 0.000 claims description 27
- 125000003729 nucleotide group Chemical group 0.000 claims description 27
- 238000010791 quenching Methods 0.000 claims description 25
- 230000000171 quenching effect Effects 0.000 claims description 25
- 230000002441 reversible effect Effects 0.000 claims description 20
- 108020004414 DNA Proteins 0.000 claims description 19
- 239000003153 chemical reaction reagent Substances 0.000 claims description 16
- 108020005196 Mitochondrial DNA Proteins 0.000 claims description 14
- 238000001514 detection method Methods 0.000 claims description 13
- 210000004369 blood Anatomy 0.000 claims description 9
- 239000008280 blood Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 5
- 208000028260 mitochondrial inheritance Diseases 0.000 claims description 5
- 230000023202 mitochondrion inheritance Effects 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 208000026350 Inborn Genetic disease Diseases 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- 210000005259 peripheral blood Anatomy 0.000 claims description 3
- 239000011886 peripheral blood Substances 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 2
- 230000000869 mutational effect Effects 0.000 claims description 2
- 208000028782 Hereditary disease Diseases 0.000 claims 1
- 208000024556 Mendelian disease Diseases 0.000 claims 1
- 238000012408 PCR amplification Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 16
- 238000013461 design Methods 0.000 abstract description 12
- 210000003470 mitochondria Anatomy 0.000 abstract description 5
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 230000002068 genetic effect Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 11
- 238000011529 RT qPCR Methods 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 229940126575 aminoglycoside Drugs 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 230000003321 amplification Effects 0.000 description 3
- 230000001351 cycling effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 231100000888 hearing loss Toxicity 0.000 description 3
- 230000010370 hearing loss Effects 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 206010064571 Gene mutation Diseases 0.000 description 2
- 206010033109 Ototoxicity Diseases 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000016361 genetic disease Diseases 0.000 description 2
- 231100000262 ototoxicity Toxicity 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010011891 Deafness neurosensory Diseases 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- DNYGXMICFMACRA-XHEDQWPISA-N Gentamicin C2b Chemical compound O1[C@H](CNC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N DNYGXMICFMACRA-XHEDQWPISA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- DNYGXMICFMACRA-UHFFFAOYSA-N gentamicin C1A Natural products O1C(CNC)CCC(N)C1OC1C(O)C(OC2C(C(NC)C(C)(O)CO2)O)C(N)CC1N DNYGXMICFMACRA-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960004744 micronomicin Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000005424 photoluminescence Methods 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000007867 post-reaction treatment Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
Cycle | Cycle Point |
Hold@95℃,10min 0secs | |
Cycling(40repeats) | Step1@95℃,hold 30secs |
Step2@60℃,hold 30secs,acquiring toCycling A(FAM/Sybr,JOE) |
72例样本 | 实时定量荧光Taqman MGB探针法 | 直接测序法 | |
MGB探针T1 | MGB探针T1+T2 | ||
C1494T突变 | 10,信号强 | 10 | 10 |
C1494C野生 | 62,信号没有或极弱 | 62 | 62 |
Claims (10)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610169639.8A CN1987463B (zh) | 2006-12-26 | 2006-12-26 | 实时定量TaqMan MGB探针试剂盒 |
PCT/CN2007/071006 WO2008077330A1 (en) | 2006-12-26 | 2007-11-02 | Taqman mgb probe for detecting maternal inherited mitochondrial genetic deafness c1494t mutation and its usage |
KR1020087019250A KR20090111268A (ko) | 2006-12-26 | 2007-11-02 | 모계 유전성 청각장애와 관련있는 미토콘드리아 유전자의C1494T 돌연변이를 검출하기 위한 TaqMan MGB프로브 및 그 용도 |
JP2009543332A JP2010514427A (ja) | 2006-12-26 | 2007-11-02 | 母性遺伝性難聴に関連するミトコンドリア遺伝子C1494T突然変異を検出するためのTaqManMGBプローブ及びその使用方法 |
EP07817197A EP1992704A4 (en) | 2006-12-26 | 2007-11-02 | TAQMAN-MGB PROBE FOR DETECTING THE C1494T MUTATION OF THE MATERNITY MITOCHONDRIAL DEPENDENCE AND USE |
US12/162,358 US20090311679A1 (en) | 2006-12-26 | 2007-11-02 | TaqMan MGB probe useful for detecting the mitochondrial gene C1494T mutation associated with maternally inherited deafness and the use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610169639.8A CN1987463B (zh) | 2006-12-26 | 2006-12-26 | 实时定量TaqMan MGB探针试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1987463A true CN1987463A (zh) | 2007-06-27 |
CN1987463B CN1987463B (zh) | 2015-04-01 |
Family
ID=38184341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200610169639.8A Active CN1987463B (zh) | 2006-12-26 | 2006-12-26 | 实时定量TaqMan MGB探针试剂盒 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20090311679A1 (zh) |
EP (1) | EP1992704A4 (zh) |
JP (1) | JP2010514427A (zh) |
KR (1) | KR20090111268A (zh) |
CN (1) | CN1987463B (zh) |
WO (1) | WO2008077330A1 (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008077330A1 (en) * | 2006-12-26 | 2008-07-03 | Zhengce Jin | Taqman mgb probe for detecting maternal inherited mitochondrial genetic deafness c1494t mutation and its usage |
CN101787391B (zh) * | 2009-01-23 | 2012-05-30 | 深圳出入境检验检疫局动植物检验检疫技术中心 | 北美大豆猝死病菌检测探针、引物、试剂盒及检测方法 |
CN102618624A (zh) * | 2011-01-26 | 2012-08-01 | 苏州市立医院 | 中国人群耳聋基因筛查用试剂盒及其使用方法 |
CN103276082A (zh) * | 2013-05-30 | 2013-09-04 | 博奥生物有限公司 | 一种检测药物性耳聋易感基因突变位点的试剂盒 |
CN103313648A (zh) * | 2010-10-01 | 2013-09-18 | 阿维利诺研究所 | 诊断Avellino角膜营养不良的系统 |
CN105506120A (zh) * | 2016-01-05 | 2016-04-20 | 石玉玲 | 线粒体突变性耳聋的多重Taqman荧光检测试剂盒 |
CN107090507A (zh) * | 2017-05-19 | 2017-08-25 | 河南大学 | 一种用于检测线粒体dna的d‑环区94g>a突变的核酸组合及其应用和试剂盒 |
CN107385023A (zh) * | 2017-06-28 | 2017-11-24 | 浙江大学 | 线粒体耳聋c1494t突变的荧光定量pcr检测试剂盒及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7700750B2 (en) * | 2003-01-09 | 2010-04-20 | Third Wave Technologies, Inc. | Connexin allele detection assays |
US20040166495A1 (en) * | 2003-02-24 | 2004-08-26 | Greinwald John H. | Microarray-based diagnosis of pediatric hearing impairment-construction of a deafness gene chip |
CN1245522C (zh) * | 2003-09-10 | 2006-03-15 | 金政策 | 母系遗传耳聋线粒体基因1555位a→g突变的检测方法及其试剂盒 |
CN1987463B (zh) * | 2006-12-26 | 2015-04-01 | 金政策 | 实时定量TaqMan MGB探针试剂盒 |
-
2006
- 2006-12-26 CN CN200610169639.8A patent/CN1987463B/zh active Active
-
2007
- 2007-11-02 EP EP07817197A patent/EP1992704A4/en not_active Withdrawn
- 2007-11-02 WO PCT/CN2007/071006 patent/WO2008077330A1/zh active Application Filing
- 2007-11-02 US US12/162,358 patent/US20090311679A1/en not_active Abandoned
- 2007-11-02 JP JP2009543332A patent/JP2010514427A/ja active Pending
- 2007-11-02 KR KR1020087019250A patent/KR20090111268A/ko not_active Application Discontinuation
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008077330A1 (en) * | 2006-12-26 | 2008-07-03 | Zhengce Jin | Taqman mgb probe for detecting maternal inherited mitochondrial genetic deafness c1494t mutation and its usage |
CN101787391B (zh) * | 2009-01-23 | 2012-05-30 | 深圳出入境检验检疫局动植物检验检疫技术中心 | 北美大豆猝死病菌检测探针、引物、试剂盒及检测方法 |
CN103313648A (zh) * | 2010-10-01 | 2013-09-18 | 阿维利诺研究所 | 诊断Avellino角膜营养不良的系统 |
CN103313648B (zh) * | 2010-10-01 | 2015-11-25 | 阿维利诺研究所 | 诊断Avellino角膜营养不良的系统 |
CN102618624A (zh) * | 2011-01-26 | 2012-08-01 | 苏州市立医院 | 中国人群耳聋基因筛查用试剂盒及其使用方法 |
CN102618624B (zh) * | 2011-01-26 | 2013-10-16 | 苏州市立医院 | 中国人群耳聋基因筛查用试剂盒及其使用方法 |
CN103276082A (zh) * | 2013-05-30 | 2013-09-04 | 博奥生物有限公司 | 一种检测药物性耳聋易感基因突变位点的试剂盒 |
WO2014190762A1 (en) * | 2013-05-30 | 2014-12-04 | Capitalbio Corporation | Kits and methods for detecting drug-induced deafness susceptibility |
CN105506120A (zh) * | 2016-01-05 | 2016-04-20 | 石玉玲 | 线粒体突变性耳聋的多重Taqman荧光检测试剂盒 |
CN105506120B (zh) * | 2016-01-05 | 2019-10-18 | 石玉玲 | 线粒体突变性耳聋的多重Taqman荧光检测试剂盒 |
CN107090507A (zh) * | 2017-05-19 | 2017-08-25 | 河南大学 | 一种用于检测线粒体dna的d‑环区94g>a突变的核酸组合及其应用和试剂盒 |
CN107385023A (zh) * | 2017-06-28 | 2017-11-24 | 浙江大学 | 线粒体耳聋c1494t突变的荧光定量pcr检测试剂盒及其应用 |
Also Published As
Publication number | Publication date |
---|---|
KR20090111268A (ko) | 2009-10-26 |
EP1992704A4 (en) | 2009-03-11 |
EP1992704A1 (en) | 2008-11-19 |
WO2008077330A1 (en) | 2008-07-03 |
US20090311679A1 (en) | 2009-12-17 |
CN1987463B (zh) | 2015-04-01 |
JP2010514427A (ja) | 2010-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1987463A (zh) | 用于检测母系遗传线粒体耳聋基因C1494T突变的TaqMan MGB探针及其用途 | |
CN104293920B (zh) | 一种用于快速检测人类vkorc1和cyp2c9基因多态性的试剂盒及其使用方法 | |
CN108690876A (zh) | 检测ace基因多态性的引物、探针及应用、试剂盒和检测方法 | |
KR101171635B1 (ko) | 변이의 검출 방법 및 그것에 이용하는 키트 | |
CN109706232B (zh) | 用于检测人类alk基因融合突变的引物、探针及试剂盒及其检测方法 | |
US9574227B2 (en) | Method for detecting variation of gene for non-diagnostic purpose based on fluorescence quenching and probe thereof | |
CN107058538B (zh) | 一种引物组合物及其组成的试剂盒和应用 | |
CN103276065A (zh) | 用于检测与遗传性耳聋相关的基因snp的引物系统及其用途 | |
CN1987462A (zh) | 用于检测母系遗传线粒体耳聋基因a1555g突变的探针及其用途 | |
CN107227361A (zh) | 用于检测cyp2c19基因多态性的引物、探针及检测试剂盒 | |
CN104830852B (zh) | 一种检测hla‑b*15:02等位基因的多重实时荧光pcr方法 | |
CN104328164A (zh) | 荧光探针杂交法检测人egfr基因突变试剂盒 | |
CN101298629A (zh) | Lrrc4基因启动子区甲基化检测在脑胶质瘤诊断中的应用及其检测系统 | |
CN103352073A (zh) | 用于检测与遗传性耳聋相关的基因snp的引物系统及其用途 | |
JP2013081450A (ja) | 多型検出用プローブ、多型検出方法、薬効判定方法及び多型検出用試薬キット | |
KR20130036146A (ko) | 다형 검출용 프로브, 다형 검출 방법, 약효 판정 방법 및 다형 검출용 시약 키트 | |
CN104328182A (zh) | 一种用于检测pdgfra基因热点突变的引物、探针、锁核苷酸探针、试剂盒及检测方法 | |
CN111118138A (zh) | 一种叶酸代谢能力基因mthfr和mtrr多态性检测试剂盒及方法 | |
CN114214402B (zh) | 血液高凝或静脉血栓风险基因多态性检测引物组、试剂盒及检测方法和应用 | |
CN106834434B (zh) | 用于检测COX-1、COX-2和GPIIIa基因多态性的核酸、试剂盒及方法 | |
CN105567847A (zh) | 一种用MspI检测人胃癌易感基因IL-1RN多态性rs9005的方法 | |
CN111172273B (zh) | 一种smn1基因检测的引物组、试剂盒及检测方法 | |
AU2009299123A1 (en) | Diagnostic markers for ankylosing spondylitis | |
CN111100924B (zh) | 一种用于检测fmr1基因cgg重复数的质控品及其应用和含有该质控品的试剂盒 | |
CN110819709A (zh) | 用于荧光定量pcr检测cyp2c9和vkorc1基因多态性的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090206 Address after: Dongguan Songshan Lake Science and Technology Industrial Park Building 2 floor 13 Keyuan pine Room 201 post encoding: 523808 Applicant after: Dongguan Aomaier Genetic Technology Co., Ltd. Address before: 46 East Tung Street, Beijing, Dongcheng District: 100027 Applicant before: Jin Zhengce |
|
ASS | Succession or assignment of patent right |
Owner name: DONGGUAN CITY AOMAIER GENE TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: JIN ZHENGCE Effective date: 20090206 |
|
ASS | Succession or assignment of patent right |
Owner name: JIN ZHENGCE Free format text: FORMER OWNER: DONGGUAN AOMAIER GENETIC TECHNOLOGY CO., LTD. Effective date: 20140403 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: DONGGUAN, GUANGDONG PROVINCE TO: 511510 QINGYUAN, GUANGDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140403 Address after: The Shang Jingfeng building 511510 Guangdong Province, Qingyuan City People's road two Applicant after: Jin Zhengce Address before: Dongguan Songshan Lake Science and Technology Industrial Park Building 2 floor 13 Keyuan pine Room 201 Applicant before: Dongguan Aomaier Genetic Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |